Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CH-20
- Development stage
- Unknown
- Lead developer
- Curanter
- Administration
- Oral
01
Overview
CH-20 is a homeopathic remedy developed and marketed by Curanter Homeo, a retail company based in Patna, India. It is available in oral formulations, specifically as drops and tablets. As a homeopathic preparation, it follows the principles of "like cures like" and extreme dilution. There is no publicly available information regarding its specific active ingredients, biological targets, or clinical trial data. It is part of a series of products (CH-19 through CH-31) sold via the company's e-commerce platform.
- Brand names
- CH-20CH20CH 20
- Other names
- CH-20 dropsCH20 dropsCH 20 dropsCH-20 tabletsCH20 tabletsCH 20 tablets
Beyond the preview
Go deeper on CH-20.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CH-20.